References
- Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med. 2008; 359(20): 2143–2153.
- Tung N, Batelli C, Allen B, Kaldate R, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. 2015; 121(1): 25–33.
- Le-Petross HT, Whitman GJ, Atchley DP, Yuan Y, et al. Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer. Cancer. 2011; 117(17): 3900–3907.
- Finch APM, Lubinski J, Moller P, Singer CF, et al. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J Clin Oncol. 2014; 32(15): 1547–1553.
- Goyal G, Fan T, Silberstein PT. Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic target. Fam Cancer. 2016; 15(3): 359–366.
- Childers CP, Childers KK, Maggard-Gibbons M, Mackino J. National estimates of genetic testing in women with a history of breast or ovarian cancer. J Clin Oncol. 2017; 35(34): 3800–3806.
- Phillips KA, Deverka PA, Hooker GW, Douglas MP. Genetic test availability and spending: where are we now? Where are we going? Health Affairs. 2018; 37(5): 710–716.
- NSGC. 2018 NSGC Professional Status Survey Executive Summary. 2018 [cited 2018 1/8/2019].
- Hoskovec JM, Bennett RL, Carey ME, DaVanzo JA, et al. Projecting the supply and demand for certified genetic counselors: a workforce study. J Genet Couns. 2018; 27(1): 16–20.
- McCuaig JM, Armel SR, Care M, Volenik A, et al. Next-generation service delivery: a scoping review of patient outcomes associated with alternative models of genetic counseling and genetic testing for hereditary cancer. Cancers. (Basel). 2018; 10(11).
- Buchanan AH, Rahm AK, Williams J. Alternate service delivery models in cancer genetic counseling: a mini-review. Frontiers in Oncol. 2016; 6(120).
- Stoll KS, Kubendran S, Cohen SA. The past, present and future of service delivery in genetic counseling: Keeping up in the era of precision medicine. Am J Med Genet C Semin Med Genet. 2018; 178(1): 24–37.
- Bradbury A, Patrick-Miller L, Harris D, Stevens E, et al. Utilizing remote real-time videoconferencing to expand access to cancer genetic services in community practices: a multicenter feasibility study. J Med Internet Res. 2016; 18(2): e23.
- Cloutier M, Gallagher L, Goldsmith C, Akiki S, et al. Group genetic counseling: an alternate service delivery model in a high risk prenatal screening population. Prenat Diagn. 2017; 37(11): 1112–1119.
- Pederson HJ, Hussain N, Noss R, Yanda C, et al., Impact of an embedded genetic counselor on breast cancer treatment. Breast Cancer Res Treat. 2018; 169(1): 43–46.
- Senter L, O'Malley DM, Backes FJ, Copeland LJ, et al. Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care. Gynecol Oncol. 2017; 147(1): 110–11.
- Schwartz MD, Valdimarsdottir HB, Peshkin BN, Mandelblatt J, et al. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol. 2014; 32(7): 618–26.
- Jacobs AS, Schwartz MD, Valdimarsdottir H, Nusbaum RH, et al. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer. Fam Cancer. 2016; 15(4): 529–539.
- NSGC. Professional Status Survey 2018. 2018 [cited 2018]. Available online at: nsgc.org. Last accessed June 14, 2019.
- Cohen SA, Nixon DM. A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital. Breast Cancer Res Treat. 2016; 159(3): 527–534.
- Petelin L, Trainer AH, Mitchell G, Liew D, et al. Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review. Genet Med. 2018; 20(10): 1145–1156.